Pierre‐Olivier Vidalain

This paper shows ritonavir and other cytochrome P450 inhibitors reduce infectious HDV virion production by inducing oxidative stress and disrupting HBs glycoprotein biogenesis in human hepatocytes.

This study identifies cis-aconitate as a dual-action antiviral and anti-inflammatory agent that reduces influenza mortality in mice by targeting viral polymerase and ERK/AKT/NF-κB signaling.

This study shows that NAD metabolism is critical for influenza A virus replication in an ex vivo mouse lung model, with PARP inhibition reducing viral production.

The paper introduces an assayome concept to optimize binary interactome mapping by combining multiple assay versions, achieving high true positive detection with minimal assays.